Medicamentsen-ligne vous propose les traitements dont vous avez besoin afin de prendre soin de votre santé sexuelle. Avec plus de 6 ans d'expérience et plus de 90.000 clients francophones, nous étions la première clinique fournissant du acheter viagra original en France à vente en ligne et le premier vendeur en ligne de Viagra dans le monde. Pourquoi prendre des risques si vous pouvez être sûr avec Medicamentsen-ligne - Le service auquel vous pouvez faire confiance.

1. Dellinger RP: Cardiovascular management of septic shock. Crit Care Med 2003; 31: 946-9552. Friedman G, Silva E, Vincent JL: Has the mortality of septic shock changed with time? Crit Care Med 1998; 26:2078-20863. Sackett DL: Rules of evidence and clinica! recommendations on the use of antithrom botic agents. Chest 1989; 95:2S-4S4. Sprung CL, Bernard GR, Dellinger RP: In troduction. Intensive Care Med 2001; 27(SuppD:S1-S25. Rivers E, Nguyen B, Havstad S, et a!: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-13776. Weinstein MP, Refler LP, Murphy JR, et al : The clinical significance of positive blood cultures: A comprehensive analysis of 500 episodes of bacteraemia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis 1983; 5:35-537. Blood F, Schmidt E, Nitenberg G, et a!: Earlier positivity of central venous versus pe ripheral blood cultures is highly predictive of catheter-related sepsis. J Clin Microbiol 1998; 36:105-1098. Mermen LA, Maki DG: Detection of bacteremia in adults: Consequences of culturing an inadequate volume of blood. Ann Intern Med 1993; 119:270-2729. McCabe WR, Jackson GG: Gram negative bacteremia. Arch Intern Med 1962; 110: 92-10010. Kreger BE, Craven DE, McCabe WR: Gram negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med 1980; 68:344-35511. Leibovici L, Shraga, Drucker M, et a! The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998; 244:379-38612. Ibrahim EH, Sherman G, Ward S, et a! The influence of inadequate antimicrobial! treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118:146 -15513. Hatala R, Dinh T, Cook Di: Once-daily aminoglycoside dosing in immunocompetent adults: A meta-analysis. Ann Intern Med 1996; 124:717-72514. Ali MZ, Goetz MB: A meta-analysis of the relative efficacy and toxicity of singe daily dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis 1997; 24:796-80915. Amsden GW, Bailow CH, Bertino JS: Pharmacokinetics and Pharmacodynamcis of Anti-infective Agents. In: Principles and Practice of Infectious Diseases. Fifth Edition. Mandeli CL, Bennett JE, Dolin R (Eds). Philadelphia, Churchill Livingstone, 2000, pp 253-26116. Hyatt JM, McKinnon PS, Zimmer CS, et al:The importance of pharmacokineticlphar macodynamic surrogate markers to out comes. Focus on antibacterial agents. Clin Pharmacokinet 1995; 28:143-16017. Jimenez MF, Marshall JC: Source control in the management of sepsis. Intensive Care Med 2001; 27:S49-S6218. Bufalari A, Ciustozzi C, Moggi L: Postoperative intraabdominal abscesses: Percutaneous versus surgical treatment. Acta Chir Belg 1996; 96:197-20019. Moss RL, Musemeche CA, Kosloske AM: Necrotizing fascitis in children: Prompt recognition and aggressive therapy improve survival. JPediatr Surg 1996; 31:1142-1 146 20. Centers for.Disease Control and Prevention:Guidelines for the Prevention of Intravascu lar Catheter-Related Infections. MMWR 2002; 51:1-2921. O'Crady NP, Alexander M, DeHinger EP, et al: Guidelines for the prevention of intra vascular catheter-related infections. Clin Infect Dis 2002; 35:1281-130722. Choi PTL, Yip C, Quinonez LC, et al: Crystalloids vs. colloids in fluid resuscitation: Asystematic review. Crit Care Med 1999; 27: 200-21023. Cook D, Guyatt G: Coiloid use for fluid resuscitation: Evidence and spin. Ann In tern Med 2001; 135:205-20824. Schierhout C, Roberts I: Fluid resuscitation with colloid or crystalloids solutions in critically iii patients: A systematic review of randomized trials. BMJ 19 316:961-964 25. Hollenberg SM, Ahrens TS, Astiz ME, et al:Practice parameters for hemodynamic support of sepsis in adult patients. Crit Care Med 1999; 27:639-66026. LeDoux D, Astiz ME, Carpati CM, et al:Effects of perfusion pressure on tissue per fusion in septic shock. Crjt Care Mec! 2000; 28:2729-273227. Regnier B, Rapin M, Gory G, et al: Haemodynamic effects of dopamine in septic shock. Intensive Care Med 1977; 3:47-5328. Martin C, Papazian L, Perrin C, et al: Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 1993; 103:1826-183129. Martin C, Viviand X, Leone M, et al: Effect of norepinephrine on the outcome of septic shock. Crit Care Med 2000; 28:2758-276530. De Backer D, Creteur J, Silva E, et al: Effects of dopamine, norepinephrine, and epi nephrine on the splanchnic circulation in septic shock: Which is best? Cr11 Care Mec! 2003; 31:1659-166731. Bellomo R, Chapman M, Finfer 5, et al:Low-dose dopamine in patients with early renal dysfunction: A placebo-controlled randomised trial. Australian and New Zea land Intensive Care Society (ANZICS) Clin ical Trials Croup. Lancet 2000; 356: 2139-214332. Kellum 1, Decker J: Use of dopaniine in acute renal failure: A meta-analysis. Crit Care Mec! 2001; 29:1526-153133. Sharshar T, Bianchard A, Paillard M, et al : Circulating vasopressin levels in septic shock. Crit Care Med. 2003; 31:1752-175834. Holmes CL, Patel BM, RusseH JA, et al: Physiology of vasopressin relevant to management of septic shock. Chest 2001; 120: 989-100235. Malay MB, Ashton RC, Landry DW, et al: Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 1999; 47:699-70536. Holmes CL, Walley KR, Chittock DR, et al: The effects of vasopressin on Haemodynamic and renal function in severe septic shock: A case series. Intensive Care Mec! 2001; 27:1416-142137. Gattinoni L, Brazzi L, Pelosi P, et al: A trial of goal-oriented hemodynamic therapy in critically ill patients. N Eng J Med. 1995; 333:1025-103238. Hayes MA, Timmins AC, Yau EHS, et al: Elevation of systemic oxygen delivery in the treatment of critically ill patients. N. Eng J Med. 1994; 330:1717-172239. Annane D, Sebille V, Charpentier C, et al :Effect of treatment with low doses of hydro cortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288:862-87140. Briegel J, Forst H, Halier M, et al: Stress doses of hydrocortisone reverse hyperdy namic septic shock: A prospective, randomized, double-blind, single-center study. Crit Care Mec! 1999; 2 7:723-73241. Bollaert PE, Charpentier C, Levy B, et al: Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998; 26:645-65042. Annane D, Sebille V, Troche G, et al: A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000; 283:1038-104543. Annane D, Cavaillon JM: Corticosteroids in sepsis: From bench to bedside? Shock 2003; 20:197-20744. Marik PE, Zaioga CP: Adrenal insufficiency during septic shock. Crit Care Med. 2003; 3 1: 141-14545. Cooper MS, Stewart PM: Corticosteroid in sufficiency in acutely ill patients. N Eng J Med 2003; 348:727-73446. Keh D, Boehnke T, Weber-Carstens 5, et al:Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: A double-b randomized, placebo controlled, crossover study. Am J Respir Crit Care Mec! 2003; 167:512-52047. Bone RC, Fisher CI, Clemmer TP: A con trolled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Eng J Med 1987; 3 17:653-65848. Cronin L, Cook DJ, Carlit J, et al: Corticosteroid treatment for sepsis: A critical appraisal and meta-analysis of the literature. Crit Care Med 1995; 23:1430-1439 49. The Veterans Administration Systemic Sep sis Cooperative Study Group: Effect on high-dose glucocorticoid therapy on mor tality in patients with clinical signs of sep sis.NEnglJMed 1987; 317:659-66550. Bernard CR, Vincent IL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. NEngi JMed 2001; 344:699-70951. Hébert PC, WelIs C, Blajchrnan MA, et al: A multicenter, randomized, controlled clinical trial of transfusion in critical care. N EngI J Med 1999; 340:409-41752. Marik PE, Sibbald WJ: Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. fA/VIA 1993; 269:3024-302953. Lorente lA, Landfn L, De Pablo R, et al: Effects of blood transfusion on oxygen transport variables in severe sepsis. Crit Care Med 1993; 21:1312-131854. Corwin HL, Cettinger A, Rodriguez RM, et al: Efficacy of recombinant human erythro poietin in the critically iii patient: A randomized double-blind, placebo-controlled trial. Crit Care Med. 1999; 27:2346-235055. Corwin HL, Gettinger A, Peari RC, et al: Efficacy of recombinant human erythropoi etin in critically ill patients. JAMA 2002; 288:2827-283556. Practice parameter for the use of fresh frozen plasma, cryoprecipitate, and plate lets. Fresh-Frozen Plasma, Cryoprecipitate, and Platelets Administration Practice Guidelines Development Task Force of the College of American Pathologists. JAMA 1994; 271:777-78157. Guidelines for red blood ceil and plasma transfusion for adults and children. Report of the Working Croup. CMAJ 1997; 156(Suppl):S1-S2458. Practice guidelines for blood component therapy. A report by the American Society of Anaesthesiologists Task Force on Blood Component Therapy. Anaesthesiology 1996; 84:732-74759. Warren BL, Eid A, Singer P, et al: High-dose antithrombin III in severe sepsis. A randomized controlled trial. JAMA 2001; 286: 1869-187860. Amato MB, Barbas CS, Medeiros DM, et al: Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Eng J Med 1998; 338:347-35461. Stewart TE, Meade MO, Cook DJ, et al: Evaluation of a ventilation strategy to pre vent barotrauma in patients at high risk for acute respiratory distress syndrome. Pres sure- and Volume-Limited Ventilation Strategy Croup. N Eng J Med 1998; 338:355-36162. Brochard L, Roudat-Thoraval F, Roupie E, et al: Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. The Multicenter Trial Group on Tidal Volume reduction in ARDS. Am J Respir Crit Care Med. 1998; 158:1831-183863. Brower RG, Shanholtz CB, Fessier HE, et al: Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med 1999; 27:1492-149864. Brower RG, Fessler HE: Mechanical ventilation in acute lung injury and acute respiratory distress syndrome. Curr Chest Med 2000; 21:491-51065. Eichacker PQ, Gerstenberger EP, Banks SM, et al: Meta-analysis of acute lung injury and acute respiratory distress syndrome tn- ala testing low tidal volumes. Am J Respir Crit Care Mec! 2002; 166:1510-151466. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Eng J Med 2000; 342:1301-130867. Hickling KG, Walsh J, Henderson S, et al: Low mortality rate in adult respiratory distress syndrome using low-volume, pres sure-limited ventilation with permissive hypercapnia: A prospective study. Crit Care Med 1994; 22:1568-157868. Bidani A, Tzouanakis AE, Cardenas VJ, et al:Permissive hypercapnia in acute respiratory failure. Fa/l'lA 272:957-96269. Marini JJ, Ravenscraft SA: Mean airway pressure: Physiologic determinants and clinical importance-Part I: Physiologic de terminants and measurements. Crit Care Med 1992; 20:1461-147270. Gattinoni L, Marcolin R, Caspani ML, et al:Constant mean airway pressure with different patterns of positive pressure breathing during the adult respiratory distress syndrome. Bui! Eur Physiopathol Respir 1985; 2 1:275-27971. Pesenti A, Marcolin R, Prato P, et al: Mean airway pressure vs. positive end-expiratory pressure during mechanical ventilation. Crit Care Med 1985; 13:34-3772. Stocker R, Neff T, Stein 5, et al: Prone positioning and low-volume pressure limited ventilation improve survival in patients with severe ARDS. Chest 1997; 111: 1008 -10 1773. Lamm WJ, Graham MM, Albert RE: Mechanism by which prone position improves oxygenation in acute lung injury. Am J Respir Crit Care Med.1994; 150:184-19374. Jolliet P, Bulpa P, Chevrolet JC: Effects of the prone position on gas exchange and hemodynamics in severe acute respiratory distress syndrome. Crit Care Mec! 1998; 26: 1977-198575. Gattinoni L, Tognoni G, Pesenti A, et al: Effect of prone positioning on the survival of patients with acute respiratory failure. NEng J Med. 2001; 345:568-57376. Chatte G, Sab JM, Dubois JM, et al: Prone position in mechanically ventilated patients with severe acute respiratory failure. Am Respir Crit Care Med 1997; 155:473-47877. Drakulovic M, Torres A, Bauer T, et al: Su pine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: A randomised trial. Lancet 1999; 354:1851-185878. Esteban A, Alia I, Tobin MJ, et al: Effect of spontaneous breathing trial duration on outcome of attempts to discontinue mechanical ventilation. Spanish Lung Failure Collaborative Group. Am J Respir Crit Care Med 1999; 159:512-51879. Ely EW, Baker AM, Dunagan DP, et al: Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N. Eng. J. Med 1996; 335:1864-186980. Esteban A, Alia I, Gordo F, et al: Extubation outcome after spontaneous breathing trials with T-tube or pressure support ventilation. The Spanish Lung Failure Collaborative Group. Am J Respir Crit Care Med 1997; 156:459 -46581. KolIef MH, Levy NT, Ahrens TS, et al: The use of continuous IV sedation is associated with prolongation of mechanical ventilation. Chest 1998; 114:541-54882. Kress JP, Pohlman AS, O'Connor MF, et al:Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Eng J Med. 2000; 342: 1471-147783. BrookAD, Ahrens TS, Schaiff R, et al: Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 1999; 27:2609-261584. Giostra E, Magistris MR, Pizzolato G, et al: Neuromuscular disorder in intensive care unit patients treated with pancuronium bromide. Occurrence in a cluster group of seven patients and two sporadic cases, with electrophysiologic and histologic examination. Chest 1994; 106:210-22085. Rossiter A, Souney PF, McGowan S, et al:Pancuronium-induced prolonged neuromuscular blockade. Crit Care Mec! 1991; 19:1583-158786. Partridge BL, Abrams JH, Bazemore C, et al: Prolonged neuromuscular blockade after long-term infusion of vecuronium bromide in the intensive care unit. Crit Care Med 1990; 18:1177-117987. Vandenheyden BA, Reynolds HN, Gerold KB, et al: Prolonged paralysis after long term vecuronium infusion. Crit Care Med 1992; 20:304-30788. Meyer KC, Prielipp RC, Grossman JE, et al: Prolonged weakness after infusion of atracurium in two intensive care unit patients. Anesth Analg 1994; 78:772-77489. Manthous CA, Chatila W: Prolonged weak ness after withdrawal of atracurium. Am Respir Crit Care Mec! 1994; 150:1441-144390. Prielipp RC, Coursin DB, Scuderi PE, et al: Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients. Anesth Analg 1995; 81:3-1291. Brandom BW, Yellon FF, Lloyd ME, et al: Recovery from doxacurium infusion administered to produce immobility for more than four days in pediatric patients in the intensive care unit. Anesth Analg 1997; 84: 3 07-3 1492. Rudis Ml, Sikora CA, Angus E, et al: A prospective, randomized, controlled evalua tion of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients. Crit Care Med. 1997; 25:25575-2558393. Frankel H, Jeng J, Tilly E, et al: The impact of implementation of neuromuscular blockade monitoring standards in a surgical intensive cane unit. Am Surg 1996; 62: 503-50694. van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in the critically ill patients. N Eng J Med 2001; 345: 1359 -136795. Finney SJ, Zekveld C, Elia A, et al: Glucose control and mortality in critically ill patients. JAMA 2003; 2041-204796. Van den Berghe G, Wouters PJ, Bouillon R, et al: Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003; 31:359-36697. Klein 5, Kinney J, Jeejeebhoy K, et al: Nutrition support in clinical practice: Review of published data and recommendations for future research directions. A summary of a conference sponsored by the National Institute of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition. Am Cur Nutr 1997; 66:683-70698. Mehta RL, McDonald B, Gabbai FB, et al: A randomized clinical trial of continuous versus intermittent dialysis for acute renal fail one. Kidney Int. 2001; 60:1154-116399. Kellum J, Angus DC, Johnson JP, et al: Continuous versus intermittent renal replacement therapy: A meta-analysis. Inten sive Care Med. 2002; 28:29-37100. Cooper DJ, Walley KR, Wiggs BR, et al: Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis: A prospective, controlled clinical study. Ann Intern Med! 1990; 112: 492-498101. Mathieu D, Nervier R, Bill and V, et al: Effects of bicarbonate therapy on hemody namics and tissue oxygenation in patients with lactic acidosis: A prospective, con trolled clinical study. Crit Care Med! 1991; 19: 1352-1356102. Cade JF: High risk of the critically iii for venous thromboembolism. Crit Care Med.
1982; 10:448-450103. Belch JJ, Lowe GD, Ward AG, et al: Prevention of deep vein thrombosis in medical patients by low-dose heparin. Scott Med 1981; 26:115-117104. Samama MM, Cohen AT, Darmon JY, et al: A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Eng. J. Med 1999; 341: 793-800105. Borrego E, Bank S, Margolis I, et al : Comparison of antacid and sucralfate in the prevention of gastrointestinal bleeding in pa tients who are critically ill. Am J Med 1985; 79:62-64106. Bresalier RS, Grende.JH, Cello JP, et al : Sucralfate versus titrated antacid for the prevention of acute stress-related gastrointestinal haemorrhage in critically ill patients. Am JMed 1987; 83:110-116107. Cook D, Guyatt G, Marshall , et al: A comparison of Sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. NEnglJMed 1998; 338:791-797108. Stothert JC, Simonowitz DA, Dellinger EP, et al : Randomized prospective evaluation of cimetidine and antacid control of gastric pH in the critically ill Ann Surg 1980; 192: 169-174109. Pollard Ai, Britto J, NadelS, et al Emer gency management of meningococcal disease. .4rch Dis Child 1999; 80:290-296110. Kanter RK, Zimmerman JJ, Strauss RH, et al : Paediatric emergency intravenous access. Evaluation of a protocol Am i Dis Child 1986; 140:132-134111. Ngo NT, Cao XT, Kneen R, et al: Acute management of dengue shock syndrome: A randomized double-blind comparison of 4 intravenous fluid regimens in the first hour. Clin Infect Dis 2001; 32:204-213112. Carcillo JA, Davis AL, Zaritsky A: Role of early fluid resuscitation in pediatric septic shock. JAMA 1991; 266:1242-1245113. Powell KR, Sugarman LI, Eskenazi AE, et al: Normalization of plasma arginine vaso pressin concentrations when children with meningitis are given maintenance plus re placement fluid therapy. J Pediatr 1991; 117: 515-522114. Ceneviva G, Paschail lA, Maffei F, et al: Hemodynamic support in fluid-refractory pediatric septic shock. Pediatrics 1998; 102: e19115. Keeley SR, Bohn DI: The use of inotropic and afterload-reducing agents in neonates. Clin Perinatol 1988; 15:467-489116. Roberts JD Jr, Fineman JR, Morin FC III, et al: Inhaled nitric oxide and persistent pulmonary hypertension of the new born. Inhaled Nitric Oxide Study Group. N Eng J Med 1997; 336:605-610117. Barton P, Garcia J, Kouatli A, et al: Hemodynamic effects of i. v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, international study. Chest 1996; 109:1302-1312118. Lindsay CA, Barton P, Lawless S, et al: Pharmacokinetics and pharmacodynamics of milrinone lactate in pediatric patients with septic shock. i Pediatr 1998; 132:329 -334119. Irazuzta lE, Pretzlaff RK, Rowin ME: Amrinone in pediatric refractory septic shock:An open-label pharmacodynamic study. Pediatric Group Care Med 2001; 2:24-28120. Lauterbach R, Pawlick D, Kowalczyk D, et al: Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: A placebo controlled double-blind trial. Crit Care Med 1999; 27:807-814121. Carciilo JA, Fields AI, American College of Critical Care Medicine Task Force Committee Members: Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med 2002; 30:1365-1378122. De Kleijn ED, Joosten KF, Van Rijn B, et al : Low serum cortisol in combination with high adrenocorticotrophic hormone con centrations are associated with poor out come in children with severe meningococcal disease. Pediatr Infect Dis 2002; 21: 330 -336123. Riordan FA, Thomson AP, Ratciiffe JM, et al: Admission cortical and adrenocorticotro phic hormone levels in children with me ningococcal disease: Evidence of adrenalin sufficiency? Crit Care Med 1999; 27: 2257-226 1124. Mio M, U T, Aye M, et a!: Hydrocortisone in the management of dengue shock syndrome. Southeast Asiari Trop Med Public Health 1975; 6:573-579125. Sumarmo, Talogo W, Asrin A, et a!: Failure of hydrocortisone to affect outcome in dengue shock syndrome. Pediatrics 1982; 69: 45-49126. Hazelzet JA, de Kleijn ED, de Groot R: Endothelial protein C activation in meningo coccal sepsis. N Eng J Med 2001; 345: 1776-1777127. de Kleijn ED, de Groot R, Hack CE, et al:Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purport fulminans: A randomized, double-blinded, placebo-controlled, dose-finding study. Crit Care Med 2003; 31:1839-1847128. Bilgin K, Yaramis A, Haspolat K, et al: A randomized trial of granulocyte-rnacroph age colony-stimulating factor in neonates with sepsis and neutropenia. Pediatrics : 2001; 107:36-41129. La Gamma EF, De Castro MH: What is the rationale for the use of granulocyte and granulocyte-macrophage colony stimulating factors in the neonatal intensive care unit? Acta Paediatr SappI 2002; 91: 109 -116130. Chaibou M, Tucci M, Dugas MA, et al: Clinically significant upper gastrointestinal bleeding acquired in a pediatric intensive care unit: A prospective study. Pediatrics :1998; 102:933-938131. Gauvin F, Dugas M, Chaibou M, et a!: The impact of clinically significant upper gastrointestinal bleeding in a pediatric intensive care unit. Pediatr Crit Care Med 2001; 2:294-298132. Alejandria MM, Lansang MA, Dans LF, et al:Intravenous immunoglobulin for treating sepsis and septic shock. Cochrane Database Syst Rev 2002; (1):CDOO1O9O133. Meyer DM, Jessen ME: Results of extracorporeal membrane oxygenation in children with sepsis. The Extracorporea! LifeSupp6rt Organization. Ann Thorac Surg 1997; 63: 756-761134. Goldman AP, Kerr SI, Butt W, et a!: Extracorporeal support for intractable cardiorespiratory failure due to meningococcal disease. Lancet 1997; 349:466-469135. Brochard L, Rauss A, Benito S, et a!: Com parison of three methods of graduai with drawal from ventilatory support during weaning from mechanical ventilation. Am Respir Crit Care Med


Microsoft word - orig_kolmas sija_jouni mölsä_odysseus thessalonikissa.doc

Armo kuuluu vain ihmisille, ei instituutioille. Pääministeri Anneli Jäätteenmäen korvat olivat tulleet hänelle kalliiksi. Jäätteenmäki oli noussut keväällä 2003 hallituksen johtoon vaalikampanjalla, jossa keskeinen rooli oli salaisilla Irak-papereilla. Niillä hän oli mielikuvissa kytkenyt pääministeri Paavo Lipposen ja Sdp:n Yhdysvaltojen johtamaan Irak-haukkojen rintamaan. Til

REFLEXIONES SOBRE LA SA LUD Un anterior número de esta revista se ocupó de la educación, el tema de este número es la salud. Aplicar políticas sociales que mejoren la salud es a la vez más sencil o y más complicado que hacerlo en educación. Es más sencil o porque una buena salud colectiva en lo corporal (la salud mental es otra cosa) puede obtenerse aplicando unas pocas medidas que son

Copyright © 2010-2014 Pharmacy Pills Pdf